Deccan Health Care Ltd

AGM Details

• AGM held on late-September 2026 at 12:00 PM via VC/OAVM.
• Venue deemed at registered office; meeting conducted via VC/OAVM.
• Attendees: 26 members attended via VC/OAVM.
• Chairman elected for the meeting.
• E-voting window: 27–29 Sep 2026; cut-off: 25 Sep 2026.
• Pre-registered Speakers interacted; queries addressed.
• Scrutinizer appointed for e-voting.
• Results to be disseminated and posted on website.

Key Resolutions

• Resolution 1 (ordinary): Adopt standalone and consolidated financial statements.
• Resolution 2 (ordinary): Director re-appointment by rotation.

Voting Status

• Voting results to be disclosed later; no outcome announced yet.

Director Changes

• Director up for rotation and proposed for re-appointment.

Deccan Health Care Ltd: Trading window closed for Designated Persons & immediate relatives from 01 October 2026; will reopen 48 hours after the announcement of unaudited financial results for the quarter and half-year ended 30 September 2026.

Financial snapshot

• Standalone revenue from operations: 8,917.97 Lakhs, up 18.7% YoY.
• Standalone PAT: 229.04 Lakhs; up 91.2% YoY.
• Standalone EPS: 0.93 INR; up 66.1% YoY.
• Consolidated revenue from operations: 8,191.35 Lakhs; up 9.1% YoY.
• Consolidated PAT: 248.76 Lakhs; up 114.7% YoY.
• Standalone net margin: 2.57%; improved from 1.59%.
• Current ratio: 4.26x; liquidity comfortable.
• Total borrowings: ₹396.20 Lakhs; net debt ₹231.77 Lakhs; debt equity 0.04x.
• Equity share capital rose to ₹2,474.92 Lakhs after warrant conversions.

Strategy & pillars

• Six growth pillars guide DHCL: Science, Digital, Manufacturing, Global, People, Preventive Healthcare.
• Weight Wellness portfolio launched December 2025; market traction evident.
• Hydration and Sports Nutrition expansion underway.
• UAE private label and Africa registrations advance global growth.
• BeYoung Store and OTC First strengthen direct consumer access.
• Tier 2/3 rural India range broadens affordability and access.

Product & innovation

• FY26 launches: Neurovit MC Total Advance, Cardtidecc, ENERGYDECC.
• Natural Iron Fruit Bar advances iron nutrition; AIIMS study completed.
• Weight Wellness and Lifestyle kit anchors a new category.
• R&D emphasizes science-backed formulations across wellness categories.
• Hydration and sports nutrition product pipeline under development.

Capital & liquidity

• Equity capital up to ₹2,474.92 Lakhs; 24,749,180 shares issued.
• Convertible warrants converted: 13,23,667 shares; ₹132.37 Lakhs added.
• Total borrowings ₹396.20 Lakhs; cash ₹162.17 Lakhs.
• Net debt to equity ratio: 0.04x; current ratio: 4.26x.
• No dividend declared for FY2025-26.

Governance & CSR

• FY25-26 board changes; Mohak Gupta appointed Executive Director.
• Governance: 10 board meetings; independent directors form majority.
• CSR not applicable under CSR thresholds.
• Secretarial updates: CS appointments, waiver filings; penalties noted.

Audit & risk

• Revenue recognition identified as key audit matter; controls tested.
• Internal financial controls deemed adequate and effective.
• Tax litigations disclosed; material contingent liabilities noted.

Outlook & risks

• FY2026-27 focus on scaling Wellness Mart and domestic distribution.
• Expand Weight Wellness, Hydration and international market-entry initiatives.
• Regulatory, supply-chain and raw material risk persist; macro conditions could impact margins.

Financial results and audit status

• Board approved unaudited standalone and consolidated results for quarter ended 30 June 2026 with Limited Review Report.
• Audit Committee recommended the results prior to board approval (meeting on 14 August 2026).
• Statutory Auditors Keyur Shah & Associates issued a Limited Review Report on the standalone results.
• Report states no material misstatement and that an audit opinion was not provided.
• Results to be uploaded on the company website.
• Single-segment nutraceutical business; segment reporting not applicable.
• Status of investor complaints: NIL.

Meeting Details

• Date: Friday, 14 August 2026; time and venue not disclosed.

Key Agenda Items

• Consider and approve unaudited standalone and consolidated financial results for the quarter ended 30 June 2026.

Other Notes

• Trading window closed for designated persons, relatives and insiders since July 1, 2026; opens 48 hours after results.

Res 1: Kataria appointment

• Special resolution to regularize Bhupendra Singh Kataria as Non-Executive Independent Director.
• Promoter group not interested; total votes polled 6,836,571; in favour 6,834,171; against 2,400.

Res 2: Bisht appointment

• Special resolution to regularize Pratiksha Bisht as Non-Executive Independent Director.
• Promoter group not interested; total votes polled 6,836,571; in favour 6,834,171; against 2,400.

Res 3: Manju Singh appointment

• Special resolution to regularize Manju Singh as Non-Executive Independent Director.
• Promoter group not interested; total votes polled 6,836,571; in favour 6,834,171; against 2,400.

Pratiskha Bisht

• Pratiskha Bisht: Regularized Independent Director for 5-year term from 25-Apr-2026; real estate professional; Audit/CSR/Nomination committees.

Manju Singh

• Manju Singh: Regularized Independent Director for 5-year term from 25-Apr-2026; social services professional; NIL relationships; Audit/CSR/Nomination committees.

Bhupendra Singh Kataria

• Bhupendra Singh Kataria: Regularized Independent Director for 5-year term from 25-Apr-2026; retired government officer; NIL relationships; Audit/CSR/Nomination committees.

Dematerialisation status

• No dematerialisation or rematerialisation requests were received; entire holding is in demat form.